Tag: eye

High-tech Health for Students: Health-E Commerce® Highlights 10 Ways to Use Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs) for Digital Healthcare Products...

Tax-free FSA and HSA funds can be used to purchase health devices at FSA Store and HSA Store that treat conditions like acne, diabetes,...

Vivakor Strengthens Executive Leadership Team

Strategic COO and CFO Appointments Enhance Operational and Financial Capabilities

Power in Partnership: Indigenized Energy and Freedom Forever Bring Solar to Indian Country

BISMARCK, N.D., Aug. 13, 2025 /PRNewswire/ -- Indigenized Energy, a Native-led nonprofit dedicated to advancing tribal energy sovereignty, is proud to announce the completion of...

Back to Smart: Hisense Rolls Out Back-to-School Deals Across the GCC

Save More This School Season with Bundles, Gifts, and Special Offers on TVs, Appliances & More DUBAI, UAE, Aug. 13, 2025 /PRNewswire/ -- As...

Back to Smart: Hisense Rolls Out Back-to-School Deals Across the GCC

Save More This School Season with Bundles, Gifts, and Special Offers on TVs, Appliances & More DUBAI, UAE, Aug. 13, 2025 /PRNewswire/ -- As...

Top 3 Financial Stocks: Smart Investments for Savvy Women by Jessie Harper

Hey lovely ladies! 💖 Let's dive into the world of financial stocks and see why a few big names are looking like hidden gems...

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S.Expansion is part of AbbVie's previously announced commitment...

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma

The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System CAMPBELL, Calif., Aug. 12, 2025 /PRNewswire/...

Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference

ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis’ management will be participating in the H.C Wainwright 5^th Annual Ophthalmology Virtual Conference on August 13, 2025.

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsEye

Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak — Product Sold Nationwide...

First-Ever Edie Harper Tile Collection Debuts at Motawi Tileworks

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

Tag: eye

High-tech Health for Students: Health-E Commerce® Highlights 10 Ways to Use Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs) for Digital Healthcare Products...

Vivakor Strengthens Executive Leadership Team

Power in Partnership: Indigenized Energy and Freedom Forever Bring Solar to Indian Country

Back to Smart: Hisense Rolls Out Back-to-School Deals Across the GCC

Back to Smart: Hisense Rolls Out Back-to-School Deals Across the GCC

Top 3 Financial Stocks: Smart Investments for Savvy Women by Jessie Harper

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma

Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference

Chevrolet’s Record-Breaking Success: Empowering Women to Invest in Thriving Automotive Trends

Dylan Field’s IPO Dream — Figma’s Not a Sure Bet

Coalax Lancer300 Empowers Solo Creators with Modular Gear and Patented Magic Arm

DDB Technology Redefines Innovation by Transforming Business Models, Not Just Products

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us